Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patientsBetti Giusti, Gian Franco Gensini, Ilaria Sestini et al.|Pharmacogenetics and Genomics|2007Cited by 228
Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent ThrombosisBetti Giusti, Gian Franco Gensini, Anna Maria Gori et al.|The American Journal of Cardiology|2009Cited by 222